Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Radiotherapy is one of the most successful cancer therapies. Here the effect of irradiation on antigen presentation by MHC class I molecules was studied. Cell surface expression of MHC class I molecules was increased for many days in a radiation dose-dependent manner as a consequence of three responses. Initially, enhanced degradation of existing proteins occurred which resulted in an increased intracellular peptide pool. Subsequently, enhanced translation due to activation of the mammalian target of rapamycin pathway resulted in increased peptide production, antigen presentation, as well as cytotoxic T lymphocyte recognition of irradiated cells. In addition, novel proteins were made in response to gamma-irradiation, resulting in new peptides presented by MHC class I molecules, which were recognized by cytotoxic T cells. We show that immunotherapy is successful in eradicating a murine colon adenocarcinoma only when preceded by radiotherapy of the tumor tissue. Our findings indicate that directed radiotherapy can improve the efficacy of tumor immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“irradiation can also increase tumor antigenicity through enriching the pool of antigenic peptides”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Reits et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“folding the HLA-A1 heavy chain with peptides CGI-51(206–215), MSH6(469–478), and F-box protein Fbl7(335–362) and human β2m as described (51).”
BackgroundDNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
Error-Tolerant Identification of Peptides in Sequence Databases by Peptide Sequence Tags
Mann, M., & Wilm, M. (1994) · Analytical Chemistry · doi:10.1021/ac00096a002 · Cited by 1,468
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,388
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966 · cited 3×
“This is probably not due only to up-regulation of MHC class I expression because mTOR activation will have more general eff ects on protein expression including up-regulation of Fas, ICAM-1 (38), and interferon expression (33, 34).”
BackgroundTraversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
Use of a Monoclonal Antibody (W6/32) in Structural Studies of HLA-A,B,C Antigens
Parham, P., Barnstable, C. J., & Bodmer, W. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.1.342 · Cited by 673
Garnett, C. T., Palena, C., Chakarborty, M., Tsang, K.-Y., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1525 · Cited by 557
Self-citationQuantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing
Princiotta, M. F., Finzi, D., Qian, S.-B., Gibbs, J., Schuchmann, S., Buttgereit, F., Bennink, J. R., & Yewdell, J. W. (2003) · Immunity · doi:10.1016/s1074-7613(03)00051-7 · Cited by 521
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
Ahn, K., Gruhler, A., Galocha, B., Jones, T. R., Wiertz, E. J. H. J., Ploegh, H. L., Peterson, P. A., Yang, Y., & Früh, K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80349-0 · Cited by 477 · cited 1×
“The human CMV protein US6 inhibits and arrests conformational changes in TAP (18, 19).”
BackgroundChakraborty, M., Abrams, S. I., Camphausen, K., Liu, K., Scott, T., Coleman, C. N., & Hodge, J. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6338 · Cited by 467
Self-citationMaking sense of mass destruction: quantitating MHC class I antigen presentation
Yewdell, J. W., Reits, E., & Neefjes, J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1250 · Cited by 445
Self-citationThe biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route
Neefjes, J. J., Stollorz, V., Peters, P. J., Geuze, H. J., & Ploegh, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90224-3 · Cited by 439
Self-citationChakraborty, M., Abrams, S. I., Coleman, C. N., Camphausen, K., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0073 · Cited by 435
Self-citationYee, C., Savage, P. A., Lee, P. P., Davis, M. M., & Greenberg, P. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2227 · Cited by 415
The major substrates for TAP in vivo are derived from newly synthesized proteins
Reits, E. A. J., Vos, J. C., Grommé, M., & Neefjes, J. (2000) · Nature · doi:10.1038/35008103 · Cited by 415
Self-citationA Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter
Hengel, H., Koopmann, J.-O., Flohr, T., Muranyi, W., Goulmy, E., Hämmerling, G. J., Koszinowski, U. H., & Momburg, F. (1997) · Immunity · doi:10.1016/s1074-7613(00)80350-7 · Cited by 315
Workshop R: Tumor Immunology, Abstract R1 bis R30
(2001) · Immunobiology · doi:10.1016/s0171-2985(04)70018-2 · Cited by 312
Kozjak, V., Wiedemann, N., Milenkovic, D., Lohaus, C., Meyer, H. E., Guiard, B., Meisinger, C., & Pfanner, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300442200 · Cited by 311
Reits, E., Griekspoor, A., Neijssen, J., Groothuis, T., Jalink, K., van Veelen, P., Janssen, H., Calafat, J., Drijfhout, J. W., & Neefjes, J. (2003) · Immunity · doi:10.1016/s1074-7613(02)00511-3 · Cited by 299
Self-citationRecycling MHC class I molecules and endosomal peptide loading
Grommé, M., Uytdehaag, F. G. C. M., Janssen, H., Calafat, J., van Binnendijk, R. S., Kenter, M. J. H., Tulp, A., Verwoerd, D., & Neefjes, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10326 · Cited by 289
Self-citationReits, E., Neijssen, J., Herberts, C., Benckhuijsen, W., Janssen, L., Drijfhout, J. W., & Neefjes, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00074-3 · Cited by 261
Self-citationGermeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F., Lethé, B., De Plaen, E., Velu, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041379 · Cited by 232
Neefjes, J. J., & Ploegh, H. L. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180522 · Cited by 223
Self-citationATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair
Gu, L. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.5.1173 · Cited by 220
Firat, H., Garcia-Pons, F., Tourdot, S., Pascolo, S., Scardino, A., Garcia, Z., Michel, M.-L., Jack, R. W., Jung, G., Kosmatopoulos, K., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10<3112::aid-immu3112>3.0.co;2-q · Cited by 176
Yewdell, J. W. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02030-x · Cited by 170
GAUGLER, C. S. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143428 · Cited by 163
The Abscopal Effect in Malignant Lymphoma and Its Relationship to Lymphocyte Circulation
Nobler, M. P. (1969) · Radiology · doi:10.1148/93.2.410 · Cited by 158
Robbins, P. F., Kantor, J. A., Salgaller, M. L., Hand, P. H., Fernsten, P. D., & Schlom, J. (1991) · PubMed · Cited by 150
Self-citationBeekman, N. J. C. M., van Veelen, P. A., van Hall, T., Neisig, A., Sijts, A. J. A. M., Camps, M. G. M., Kloetzel, P., Neefjes, J., Melief, C. J. M., & OSSENDORP, F. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1898 · Cited by 107
Self-citationvan Ham, S. M., van Lith, M., Lillemeier, B. F., Tjin, E. P. M., Grüneberg, U., Rahman, D., Pastoors, L., van Meijgaarden, K. E., Roucard, C., Trowsdale, J., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1127 · Cited by 106
Self-citationIrradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells.
Quarmby, S., Hunter, R. D., & Kumar, S. (2000) · PubMed · Cited by 94
CD1high B cells: a population of mixed origin
Makowska, A., Faizunnessa, N. N., Anderson, P. O., Midtvedt, T., & Cardell, S. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10<3254::aid-immu3254>3.0.co;2-0 · Cited by 86
Peptide motifs of HLA-A1,-A11,-A31, and-A33 molecules
Falk, K., Rötzschke, O., Takiguchi, M., Grahovac, B., Gnau, V., Stevanović, S., Jung, G., & Rammensee, H. (1994) · Immunogenetics · doi:10.1007/bf00167086 · Cited by 85
Neefjes, J., Hämmerling, G. J., & Momburg, F. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.1971 · Cited by 80
Self-citationKudo‐Saito, C., Schlom, J., & Hodge, J. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1380 · Cited by 77
Self-citationSunavala‐Dossabhoy, G., Fowler, M., & Benedetti, A. D. (2004) · BMC Molecular Biology · doi:10.1186/1471-2199-5-1 · Cited by 67
Yang, J. C.-H., & Perry-Lalley, D. M. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200003000-00001 · Cited by 64
Santin, A. D., Hermonat, P. L., Hiserodt, J. C., Chiriva‐Internati, M., Woodliff, J., Theus, J. W., Barclay, D., Pecorelli, S., & Parham, G. P. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00372-6 · Cited by 64
van de Rijna, M., van Kessel, A. H. M. G., Kroezen, V., Agthoven, A. V., Verstijnen, K., Terhorst, C., & Hilgers, J. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000131967 · Cited by 51
Schaich, K. M., & Pryor, W. A. (1980) · C R C Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398009527286 · Cited by 50
Kruse, J. J. C. M., Poele, J. A. M. T., Velds, A., Kerkhoven, R. M., Boersma, L. J., Russell, N. S., & Stewart, F. A. (2004) · Radiation Research · doi:10.1667/rr3097 · Cited by 45
Rosen, E. M., Fan, S., Goldberg, I. D., & Rockwell, S. (2000) · PubMed · Cited by 43
Bártek, J., & Lukas, J. (2001) · Science · doi:10.1126/science.1066237 · Cited by 37
Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope
Ciernik, I. F., Romero, P. J., Berzofsky, J. A., & Carbone, D. P. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00226-6 · Cited by 28
Isolation of an HLA‐A2.1 extracted human minor histocompatibility peptide
de Bueger, M., Verreck, F. A. W., Blokland, E. C., Drijfhout, J. W., Amons, R., Koning, F., & Goulmy, E. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230305 · Cited by 23
Self-citationBiological Basis of Radiation Sensitivity
Rosen, E. M., Fan, S., Goldberg, I. D., & Rockwell, S. (2000) · Cited by 16
Hareyama, M., Imai, K., Ban, T., Koshiba, H., Kubo, K., Shidou, M., Oouchi, A., & Morita, K. (1988) · PubMed · Cited by 8
Research works printed but not linked: 5
- 2000, Oncology (Huntingt), 14, 741
- 1988, Nippon Igaku Hoshasen Gakkai Zasshi., 48, 1572
- 2000, Anticancer Res., 20, 3375
- 2002, Cancer Res., 62, 1462
- 1991, Cancer Res., 51, 3657
Cited by
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809697 · Cited by 2,798
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044
Self-citation
Metadata
- Authors
- Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., Griekspoor, A., Mesman, E., Verreck, F. A., Spits, H., Schlom, J., van Veelen, P., & Neefjes, J. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- 2Laboratory of Tumor Immunology and Biology
- National Institutes of Health (US)
- 4Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, and Centre for Medical Systems Biology, 2333 2A Leiden, Netherlands
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1259-1271
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3212727
- OpenAlex
- W2127733313
- Cited by
- 1,737
- References
- 53
- Citations by year
- 2026: 88 · 2025: 116 · 2024: 119 · 2023: 128 · 2022: 149 · 2021: 174 · 2020: 154 · 2019: 118 · 2018: 112 · 2017: 113 · 2016: 78 · 2015: 71 · 2014: 67 · 2013: 62 · 2012: 41
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- radiotherapy, gamma irradiation, MHC class I expression, antigen presentation, protein degradation, mTOR signaling, translation (biology), cytotoxic T lymphocytes, cancer immunotherapy, colon adenocarcinoma
- MeSH terms
- Adenocarcinoma, Animals, Colonic Neoplasms, Dose-Response Relationship, Radiation, Gamma Rays, Humans, Immunotherapy, Mice, Transgenic, Peptides, Protein Kinases, Radiotherapy, T-Lymphocytes, Cytotoxic, Protein Biosynthesis, HLA-A2 Antigen, Gene Expression Regulation, Neoplastic, Antigen Presentation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.